blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0255141

EP0255141 - Combination of active agents comprising diltiazem and acetylsalicylic acid, their preparation as well as their use in the preparation of medicaments with a thrombocyte-aggregation inhibitory activity [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  06.05.1993
Database last updated on 31.01.2025
Most recent event   Tooltip06.05.1993No opposition filed within time limitpublished on 23.06.1993 [1993/25]
Applicant(s)For all designated states
GÖDECKE AKTIENGESELLSCHAFT
Salzufer 16
D-10587 Berlin / DE
[1988/05]
Inventor(s)01 / Satzinger, Gerhard, Dr.
Im Mattenbühl 7
D-7809 Denzlingen / DE
02 / Wolf, Günter, Dr.
Wildtalstrasse 40
D-7800 Freiburg / DE
03 / Osswald, Hartmut, Prof. Dr.
Kiefernweg 1
D-7808 Waldkirch 2 / DE
04 / Weiershausen, Ute
Bundesstrasse 70
D-7803 Gundelfingen / DE
[1988/05]
Application number, filing date87111065.630.07.1987
[1988/05]
Priority number, dateDE1986362609731.07.1986         Original published format: DE 3626097
[1988/05]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report 
No.:EP0255141
Date:03.02.1988
Language:DE
[1988/05]
Type: A3 Search report 
No.:EP0255141
Date:15.11.1989
Language:DE
[1989/46]
Type: B1 Patent specification 
No.:EP0255141
Date:01.07.1992
Language:DE
[1992/27]
Search report(s)(Supplementary) European search report - dispatched on:EP26.09.1989
ClassificationIPC:A61K31/62
[1988/05]
CPC:
A61K31/60 (EP,KR,US)
C-Set:
A61K31/60, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1988/05]
TitleGerman:Wirkstoffkombination enthaltend Diltiazem und Acetylsalicylsäure, deren Herstellung sowie deren Verwendung zur Herstellung von Arzneimitteln mit einer die Thrombozyten-aggregation hemmenden Wirkung[1988/05]
English:Combination of active agents comprising diltiazem and acetylsalicylic acid, their preparation as well as their use in the preparation of medicaments with a thrombocyte-aggregation inhibitory activity[1988/05]
French:Combinaison d'agents actifs comprenant le diltiazème et l'acide acétyl salicylique, leur préparation ainsi que leur utilisation dans la préparation de médicaments ayant une activité inhibitrice de l'agrégation des thrombocytes[1988/05]
Examination procedure30.07.1987Examination requested  [1988/05]
18.10.1990Despatch of a communication from the examining division (Time limit: M04)
26.01.1991Reply to a communication from the examining division
03.07.1991Despatch of communication of intention to grant (Approval: Yes)
27.12.1991Communication of intention to grant the patent
20.03.1992Fee for grant paid
20.03.1992Fee for publishing/printing paid
Opposition(s)02.04.1993No opposition filed within time limit [1993/25]
Fees paidRenewal fee
05.07.1989Renewal fee patent year 03
07.07.1990Renewal fee patent year 04
20.12.1990Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XP]EP0214881  (SYNTHELABO [FR])
 [X]  - BIOLOGICAL ABSTRACTS/RRM 28064647; K.L. CHAN et al.: "Coronary thrombosis and subsequent lysis after a marathon", & JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(US) 1984. vol. 4, no. 6, p.1322-1325
 [XP]  - CHEMICAL ABSTRACTS, Band 106, Nr. 3, 19. Januar 1987 1987, Seite 53, Zusammenfassung Nr. 12658r, Columbus, Ohio, US; M.E. RING et al.: "Effects of oral diltiazem on platelet function: alone and in combination with "low dose" aspirin", & THROMB. RES. 1986, 44(3), 391-400
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.